Multiple Myeloma and AL Amyloidosis [PDF]
O mieloma múltiplo e a amiloidose de cadeias leves (AL) de imunoglobulina são doenças proliferativas plasmocitárias incuráveis que raramente coexistem. Cerca de 10 a 15% dos doentes com mieloma múltiplo desenvolvem amiloidose AL clinicamente sintomática,
Alcatrão, M +5 more
core
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy. [PDF]
BACKGROUND: Severe left ventricular (LV) systolic dysfunction is an uncommon complication of hypertrophic cardiomyopathy (HCM) that is associated with poor prognosis.
Biagini +22 more
core +2 more sources
Two cases of monoclonal nodular pulmonary amyloidosis and review of the literature [PDF]
Nodular pulmonary amyloidosis (NPA) is an uncommon pathology of insoluble protein depositing in pulmonary parenchyma. This localized pulmonary form of amyloidosis is most often found to contain combinations of kappa and lambda immunoglobulin light chain ...
Endicott, Kendal +4 more
core +2 more sources
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
Rajshekhar Chakraborty +5 more
semanticscholar +1 more source
Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach
Systemic immunoglobulin light-chain (AL) amyloidosis is a rare disorder arising from a plasma cell clone that produces misfolded immunoglobulin light chains, which are deposited in various tissues and organs as amyloid fibrils.
Y. Hwa +6 more
semanticscholar +1 more source
A simple voltage/mass index increases the suspicion of amyloidotic cardiomyopathy: an electrocardiographic and echocardiographic study of 767 patients with increased left ventricular wall thickness due to different causes [PDF]
Background-Amyloidotic cardiomyopathy (AC) can mimic true left ventricular hypertrophy (LVH), including hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD).
Quarta, Candida Cristina <1981>
core +1 more source
A risk stratification for systemic immunoglobulin light‐chain amyloidosis with renal involvement
Renal involvement is found in about 70% of patients with systemic immunoglobulin light‐chain (AL) amyloidosis. However, there is no risk stratification system specialized for renal AL concerning patients’ survival. Galectin‐3 (Gal‐3) has been reported to
Ting Li +10 more
semanticscholar +1 more source
Urinary Biomarkers for Kidney Disease in ATTR Amyloidosis [PDF]
Aim: The detection and prognosis of nephropathy in transthyretin amyloidosis depends on albuminuria and renal function. Knowing that urinary levels of alpha-1 microglobulin and beta-2 microglobulin reflect tubular dysfunction while urinary alpha-2 ...
Beirão, I. +5 more
core +1 more source
British Journal of Haematology, Volume 208, Issue 1, Page 329-332, January 2026.
Daniel Cancilla +14 more
wiley +1 more source

